Cefcapene
![]() | |
Systematic (IUPAC) name | |
---|---|
(6R,7R)-3-{[(Aminocarbonyl)oxy]methyl}-7-{(Z)-[2-(2-amino-4-thiazolyl)-1-oxo-2-pentenyl]amino}-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number |
135889-00-8 ![]() |
ATC code | J01DD17 (WHO) |
PubChem | CID 6436055 |
ChemSpider |
4940731 ![]() |
UNII |
4D5D3422MW ![]() |
KEGG |
D07638 ![]() |
ChEBI | CHEBI:131729 |
ChEMBL |
CHEMBL582912 ![]() |
Chemical data | |
Formula | C17H19N5O6S2 |
Molar mass | 453.49 g/mol |
| |
| |
![]() ![]() |
Cefcapene (INN) is a third-generation cephalosporin antibiotic.
|
This article is issued from Wikipedia - version of the Friday, April 15, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.